What Does The Market Want From Boeing Stock?
📉 Boeing stock fell 26.4% from August 7 to November 5, 2026, while the S&P 500 declined 5.0%, reflecting market concerns over production stability.
🛡️ Defense revenue surged 15% in Q3 2026 to $7.9 billion, driven by higher volume in classified missile and weapons programs.
✈️ Jetliner sales contracted 3% to $10.7 billion due to a less favorable mix of deliveries and factory steadying issues.
📊 Defense now represents approximately one-third of Boeing's total quarterly sales of $24.2 billion.
💰 The defense unit reported an operating margin of 6.2%, which included a $252 million one-time gain on the sale of HRL Laboratories.
📉 Without the one-time gain, the defense unit's operating margin would have been approximately 3% in the third quarter.
🔥 The jetliner unit posted a negative 6.5% operating margin, exacerbating Boeing's overall net loss of $116 million for the quarter.
📦 Boeing holds a record defense backlog of $101 billion, excluding the US Navy fighter jet contract.
💸 Management anticipates around $1 billion in higher capital spending for 2027 related to recent defense awards.
🔮 Investors are awaiting the January 2027 earnings report to assess if the defense unit can achieve high single-digit margins consistently.
- Boeing's defense business grew revenue by 15% in the third quarter of 2026, reaching $7.9 billion.
- The defense unit booked $23 billion in orders during the quarter, contributing to a record backlog of $101 billion.
- Management forecasts future defense revenue growth in the middle single digits or higher, up from low single digits previously.
- Boeing reported a net loss of $116 million for the third quarter of 2026.
- The jetliner unit's operating margin was negative 6.5%, indicating continued losses in the commercial aviation segment.
- Management does not expect steady output of 47 jets per month at the 737 factory until 2027.
- Boeing expects 737 deliveries for 2026 to fall short of its 500 target due to factory steadying delays.
- The defense unit's operating margin of 6.2% was inflated by a $252 million one-time gain on the sale of HRL Laboratories.
- Excluding the one-time gain, the defense unit's underlying operating margin would have been only about 3%.